3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Neoplasms
3
Colorectal Neoplasms
3
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Breast Neoplasms
2
Sarcoma
1
Rectal Neoplasms
1
Pancreatic Cancer Resectable
1
Lymphangioleiomyomatosis
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Gliosarcoma
1
Glioblastoma
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
COVID-19
1
Breast Neoplasms, Male
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Arthritis, Rheumatoid
1
Anatomic Stage I Breast Cancer AJCC v8
1
Adenocarcinoma of Lung
1
Interventions
Rituximab
4
Cyclophosphamide
4
ponatinib
2
Vorinostat
2
Vincristine
2
Prednisone
2
Etoposide
2
Doxorubicin
2
Brentuximab Vedotin
2
Bortezomib
2
tetulomab tetraxetan lu-177
1
pembrolizumab
1
ibrutinib
1
ibritumomab tiuxetan
1
fludarabine
1
durvalumab
1
cobomarsen
1
acalabrutinib
1
Melphalan
1
Lutetium
1
Lenalidomide
1
KW-2478
1
Imatinib Mesylate
1
Ifosfamide
1
Hsp90 inhibitor KU757
1
Cytarabine
1
Carmustine
1
Carboplatin
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immune System Diseases
×
Hydroxychloroquine
×
Clear all
No trials found.